Community Health Systems Inc

Community Health Systems Inc(CYH)股票分析

$2.760

-0.115 (-4.17%)收盤時

Loading chart…
最高
2.910
開盤
2.910
成交量加權均價
2.81
成交量
901.18K
市值
—
最低
2.755
成交金額
2.53M
企業價值/稅息折舊攤銷前利潤(TTM)
7.91

Community Health Systems, Inc. is a healthcare company. The Company's affiliates are providers of healthcare services, developing and operating healthcare delivery systems in approximately 32 distinct markets across 12 states. Its subsidiaries own or lease 60 affiliated hospitals with more than 8,000 beds and operate more than 800 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. It provides a range of general and specialized hospital healthcare services and outpatient services. Services provided through its hospitals and outpatient facilities include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. An integral part of providing these services is its network of affiliated physicians at its hospitals and affiliated businesses.

AI 分析 of Community Health Systems Inc (CYH)

持有

Community Health Systems Inc (CYH) is currently priced at $2.88, which is below the average analyst price target of $3, indicating a potential upside of about 4.17%. However, the company has a forward P/E ratio of 17.61, suggesting that it may be overvalued relative to its earnings potential. Additionally, the recent RSI of 49.24 indicates that the stock is neither overbought nor oversold, which suggests a neutral sentiment. The main risk is the company's significant debt, which stands at $9.578 billion, coupled with a negative net income of $58 million in Q1 2026, reflecting ongoing profitability challenges. Therefore, while there is some upside potential, the risks associated with financial performance and debt levels warrant a cautious approach.

分析師評級(18)

上檔空間 +32.97%
持有
1 買進
12 持有
5 賣出
目前: 2.76
最低
2.00
平均
3.67
最高
5.00

BMO Capital

2026-09-22

目標價

$3

Market Perform

Truist

2026-07-27

目標價

—

持有

UBS

2026-07-24

目標價

$3

中性

Barclays

2026-07-23

目標價

$3

減持

Truist

2026-07-14

目標價

$3

持有

估值指標

Community Health Systems Inc(CYH)目前預期本益比為 17.61,5 年平均預期本益比為 -17.53。

預期本益比

合理
5 年均值 P/E
-17.53
目前P/E
17.61
高估
51.32
低估
-86.39

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
8.47
目前EV/EBITDA
7.91
高估
9.26
低估
7.67

預期股價營收比

合理
5 年均值 P/S
0.05
目前P/S
0.04
高估
0.08
低估
0.02

Alphio AI 對 CYH 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%CYH

$4.60

情境價格

基

基準

基準 · 50%CYH

$4.15

情境價格

悲

悲觀

悲觀 · 25%CYH

$3.80

情境價格

持有 CYH 的大戶

C

Castleknight Management LP

+ 持有CYH

-7.34%

3個月報酬率

E

Eversept Partners, L.P.

+ 持有CYH

-9.17%

3個月報酬率

A

Apollo Global Management, Inc.

+ 持有CYH

-17.84%

3個月報酬率

CYH 常見問題 —— 由 Alphio AI 解答

Community Health Systems, Inc. is a healthcare company. The Company's affiliates are providers of healthcare services, developing and operating healthcare delivery systems in approximately 32 distinct markets across 12 states. Its subsidiaries own or lease 60 affiliated hospitals with more than 8,000 beds and operate more than 800 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. It provides a range of general and specialized hospital healthcare services and outpatient services. Services provided through its hospitals and outpatient facilities include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. An integral part of providing these services is its network of affiliated physicians at its hospitals and affiliated businesses. It operates in the Healthcare sector (SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC industry).

Community Health Systems Inc (CYH) is currently priced at $2.88, which is below the average analyst price target of $3, indicating a potential upside of about 4.17%. However, the company has a forward P/E ratio of 17.61, suggesting that it may be overvalued relative to its earnings potential. Additionally, the recent RSI of 49.24 indicates that the stock is neither overbought nor oversold, which suggests a neutral sentiment. The main risk is the company's significant debt, which stands at $9.578 billion, coupled with a negative net income of $58 million in Q1 2026, reflecting ongoing profitability challenges. Therefore, while there is some upside potential, the risks associated with financial performance and debt levels warrant a cautious approach.

18 analysts cover CYH: 1 rate it Buy, 12 Hold and 5 Sell. The average price target is 3.67.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易